Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN PHARMACEUTICALS vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN PHARMACEUTICALS DR. REDDYS LAB SUVEN PHARMACEUTICALS/
DR. REDDYS LAB
 
P/E (TTM) x 44.4 19.8 223.9% View Chart
P/BV x 9.5 4.5 212.6% View Chart
Dividend Yield % 0.9 0.6 143.6%  

Financials

 SUVEN PHARMACEUTICALS   DR. REDDYS LAB
EQUITY SHARE DATA
    SUVEN PHARMACEUTICALS
Mar-23
DR. REDDYS LAB
Mar-23
SUVEN PHARMACEUTICALS/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs6294,656 13.5%   
Low Rs3883,788 10.2%   
Sales per share (Unadj.) Rs52.71,481.4 3.6%  
Earnings per share (Unadj.) Rs16.2270.7 6.0%  
Cash flow per share (Unadj.) Rs18.0345.7 5.2%  
Dividends per share (Unadj.) Rs6.0040.00 15.0%  
Avg Dividend yield %1.20.9 124.6%  
Book value per share (Unadj.) Rs68.21,389.6 4.9%  
Shares outstanding (eoy) m254.57166.53 152.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x9.72.8 338.8%   
Avg P/E ratio x31.515.6 201.7%  
P/CF ratio (eoy) x28.212.2 230.9%  
Price / Book Value ratio x7.53.0 245.5%  
Dividend payout %37.114.8 251.3%   
Avg Mkt Cap Rs m129,395703,039 18.4%   
No. of employees `000NANA-   
Total wages/salary Rs m1,10546,466 2.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m13,403246,697 5.4%  
Other income Rs m46410,555 4.4%   
Total revenues Rs m13,867257,252 5.4%   
Gross profit Rs m5,73963,860 9.0%  
Depreciation Rs m47712,502 3.8%   
Interest Rs m1281,428 9.0%   
Profit before tax Rs m5,59760,485 9.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,48415,412 9.6%   
Profit after tax Rs m4,11345,073 9.1%  
Gross profit margin %42.825.9 165.4%  
Effective tax rate %26.525.5 104.1%   
Net profit margin %30.718.3 168.0%  
BALANCE SHEET DATA
Current assets Rs m11,554203,161 5.7%   
Current liabilities Rs m3,03185,721 3.5%   
Net working cap to sales %63.647.6 133.6%  
Current ratio x3.82.4 160.8%  
Inventory Days Days14879 187.4%  
Debtors Days Days302107 281.7%  
Net fixed assets Rs m9,547112,638 8.5%   
Share capital Rs m255833 30.6%   
"Free" reserves Rs m17,097230,571 7.4%   
Net worth Rs m17,352231,404 7.5%   
Long term debt Rs m461,278 3.6%   
Total assets Rs m21,101315,799 6.7%  
Interest coverage x44.743.4 103.1%   
Debt to equity ratio x00 47.6%  
Sales to assets ratio x0.60.8 81.3%   
Return on assets %20.114.7 136.5%  
Return on equity %23.719.5 121.7%  
Return on capital %32.926.6 123.7%  
Exports to sales %052.2 0.0%   
Imports to sales %016.8 0.0%   
Exports (fob) Rs mNA128,803 0.0%   
Imports (cif) Rs mNA41,484 0.0%   
Fx inflow Rs m14,672128,803 11.4%   
Fx outflow Rs m1,84841,484 4.5%   
Net fx Rs m12,82487,319 14.7%   
CASH FLOW
From Operations Rs m4,50958,875 7.7%  
From Investments Rs m-1,948-41,373 4.7%  
From Financial Activity Rs m-2,358-26,861 8.8%  
Net Cashflow Rs m202-9,073 -2.2%  

Share Holding

Indian Promoters % 9.9 26.7 37.1%  
Foreign collaborators % 50.1 0.0 -  
Indian inst/Mut Fund % 26.1 47.3 55.2%  
FIIs % 10.1 28.6 35.4%  
ADR/GDR % 0.0 15.3 -  
Free float % 40.0 58.0 68.9%  
Shareholders   70,052 257,794 27.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN PHARMACEUTICALS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on SUVEN PHARMACEUTICALS vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SUVEN PHARMACEUTICALS vs Dr. Reddys Share Price Performance

Period SUVEN PHARMACEUTICALS Dr. Reddys S&P BSE HEALTHCARE
1-Day 1.08% 2.33% 1.39%
1-Month 0.53% -3.70% -0.54%
1-Year 37.60% 36.67% 62.16%
3-Year CAGR 10.50% 11.05% 18.24%
5-Year CAGR 30.93% 17.90% 19.84%

* Compound Annual Growth Rate

Here are more details on the SUVEN PHARMACEUTICALS share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of SUVEN PHARMACEUTICALS hold a 60.0% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SUVEN PHARMACEUTICALS and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, SUVEN PHARMACEUTICALS paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 37.1%.

Dr. Reddys paid Rs 40.0, and its dividend payout ratio stood at 14.8%.

You may visit here to review the dividend history of SUVEN PHARMACEUTICALS, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.